---

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆

• Marksans Pharma reported a 20.21% increase in net sales and a 22.22% decrease in net profit for the September 2023 quarter.

• EBITDA also decreased by 2.88% compared to the same quarter last year.

• The company's EPS has decreased from Rs. 1.00 to Rs. 0.69.

https://www.moneycontrol.com/news/business/earnings/marks...

#TARSONS